explore -WSS

explore

author：focus 2025-09-30 00:44:55 - browse：6

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： UCLA team creates talking throat patch for voice disorders

leisure time

WSS

Change Healthcare outage fallout shows need for new oversight

What we know about the American soldier detained in North Korea

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Ebola: Gilead Sciences antiviral shows promise as new treatment

entertainment

explore

focus

Heart attack and stroke risk calculators need revising

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

ChatGPT in medicine: STAT answers readers' burning questions

Twill hunts for pharma partner to market its depression app

Activists slam private health insurers over coverage restrictions

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

How one medical school became remarkably diverse

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Virginia high school admissions case could be legal follow

Flagship, Pfizer team up in deal worth up to $7 billion

focus

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

UCLA team creates talking throat patch for voice disorders

Flagship, Pfizer team up in deal worth up to $7 billion

A Theranos scientist

Biden administration sends mixed signals on US soldier who crossed into North Korea

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

entertainment

Wikipedia

leisure time

Wikipedia